Erratum: Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial (The Lancet (2012) 379 (633-640))

The Lancet

Volumn 379, Issue 9816, 2012, Pages 616-

  Baselga, J ^a   Bradbury, I ^a   Eidtmann, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 84857211691     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60268-2     Document Type: Erratum

References (0)